# E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe

> **NCT03818503** · — · RECRUITING · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 2000 (estimated)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03818503
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-06-24
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03818503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03818503, "E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03818503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*